Lack of association between childhood immunizations and encephalitis in California, 1998-2008

Vaccine

Volumn 30, Issue 2, 2012, Pages 247-253

  Pahud, Barbara A ^a   Rowhani Rahbar, Ali ^a,c   Glaser, Carol ^b   Gavali, Shilpa ^b   Salibay, Catheryn J ^b   Fireman, Bruce ^c   Dekker, Cornelia L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

Adverse effects; Case centered analysis; Children; Encephalitis; Encephalopathy; Immunization; Vaccines

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHICKENPOX; CHILD; CHILDHOOD; CLINICAL OBSERVATION; CLINICAL PROTOCOL; CONTROLLED STUDY; DIPHTHERIA; DRUG SAFETY; DRUG TOLERABILITY; ENCEPHALITIS; FEMALE; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNIZATION; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MEASLES; MEDICAL RECORD REVIEW; MENINGOCOCCEMIA; MUMPS; PAPILLOMAVIRUS INFECTION; PERTUSSIS; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ROTAVIRUS INFECTION; RUBELLA; SCHOOL CHILD; TETANUS; UNITED STATES;

ADOLESCENT; CALIFORNIA; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MEASLES VACCINE; PERTUSSIS VACCINE;

EID: 84355166503     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.104     Document Type: Article

References (47)

1. United States Department of Health and Human Services. National Childhood Vaccine Injury Compensation Program, vaccine injury table. Available at: http://www.hrsa.gov/Vaccinecompensation/table.htm%23a.
2. Weibel R.E., Caserta V., Benor D.E., Evans G. Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: a review of claims submitted to the National Vaccine Injury Compensation Program. Pediatrics 1998, 101(3 Pt 1):383-387.
3. Stratton K.R., Howe C.J., Johnston R.B. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine. J Am Med Assoc 1994, 271(20):1602-1605.
4. Alderslade R.B.M., Rawson N.S.B., Ross E.M., Miller D.L. The National Childhood Encephalopathy Study: a report on 1000 cases of serious neurological disorders in infants and young children from the NCES research team 1981, Her Majesty's Stationery Office, London. Department of Health and Social Security (Ed.).
5. Ray P., Hayward J., Michelson D., Lewis E., Schwalbe J., Black S., et al. Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study. Pediatr Infect Dis J 2006, 25(9):768-773.
6. Makela A., Nuorti J.P., Peltola H. Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics 2002, 110(5):957-963.
7. Moore D.L., Le Saux N., Scheifele D., Halperin S.A. Lack of evidence of encephalopathy related to pertussis vaccine: active surveillance by IMPACT, Canada, 1993-2002. Pediatr Infect Dis J 2004, 23(6):568-571.
8. IOM IoM Adverse effects of vaccines: evidence and causality 2011, The National Academies Press, Washington, DC.
9. Sugerman D.E., Barskey A.E., Delea M.G., et al. Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated. Pediatrics 2010, 125(2):747-755.
10. Barskey A.E., Glasser J.W., LeBaron C.W. Mumps resurgences in the United States: a historical perspective on unexpected elements. Vaccine 2009, 27(44):6186-6195.
11. Centers for Disease Control and Prevention Notes from the field: pertussis-California, January-June 2010. MMWR Morb Mortal Wkly Rep 2010, 59(26):817.
12. Centers for Disease Control and Prevention Measles imported by returning U.S. travelers aged 6-23 months, 2001-2011. MMWR Morb Mortal Wkly Rep 2011, 60(13):397.
13. Centers for Disease Control and Prevention Notes from the field: measles outbreak-Hennepin County, Minnesota, February-March 2011. MMWR Morb Mortal Wkly Rep 2011, 60(13):421.
14. Freed G.L., Clark S.J., Butchart A.T., Singer D.C., Davis M.M. Parental vaccine safety concerns in 2009. Pediatrics 2009, 125(4):654-659.
15. Fitch P., Racine A. Parental beliefs about vaccination among an ethnically diverse inner-city population. J Natl Med Assoc 2004, 96(8):1047-1050.
16. Hilton S., Petticrew M., Hunt K. 'Combined vaccines are like a sudden onslaught to the body's immune system': parental concerns about vaccine 'overload' and 'immune-vulnerability'. Vaccine 2006, 24(20):4321-4327.
17. Kennedy A.M., Brown C.J., Gust D.A. Vaccine beliefs of parents who oppose compulsory vaccination. Public Health Rep 2005, 120(3):252-258.
18. Luthy K.E., Beckstrand R.L., Callister L.C. Parental hesitation in immunizing children in Utah. Public Health Nurs 2010, 27(1):25-31.
19. Kennedy A., Basket M., Sheedy K. Vaccine attitudes, concerns, and information sources reported by parents of young children: results from the 2009 HealthStyles Survey. Pediatrics 2011, peds.2010-1722N.
20. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. Recommendations of the immunization practices advisory committee (ACIP). MMWR Recomm Rep 1991, 40(RR-1):1-7.
21. Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine. Recommendations of the advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1993, 42(RR-13):1-15.
22. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997, 46(RR-7):1-25.
23. Advisory Committee on Immunization Practices Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000, 49(RR-9):1-35.
24. Advisory Committee on Immunization Practices, Fiore A.E., Wasley A., Bell B.P. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 55(RR-7):1-23.
25. Bilukha O.O., Rosenstein N., National Center for Infectious Diseases CfDC and Prevention Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005, 54(RR-7):1-21.
26. Broder K.R., Cortese M.M., Iskander J.K., et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 55(RR-3):1-34.
27. Cortese M.M., Parashar U.D., Centers for Disease Control and Prevention Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009, 58(RR-2):1-25.
28. Fiore A.E., Shay D.K., Broder K., et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009, 58(RR-8):1-52.
29. Markowitz L.E., Dunne E.F., Saraiya M., et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56(RR-2):1-24.
30. Mast E.E., Weinbaum C.M., Fiore A.E., et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006, 55(RR-16):1-33. quiz CE 31-34.
31. National Center for Infectious and Respiratory Diseases, Centers for Disease Control and Prevention Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009, 58(RR-10):1-8.
32. Prevots D.R., Burr R.K., Sutter R.W., Murphy T.V., Advisory Committee on Immunization Practices Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000, 49(RR-5):1-22.
33. Glaser C.A., Gilliam S., Schnurr D., et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis 2003, 36(6):731-742.
34. Glaser C.A., Honarmand S., Anderson L.J., et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006, 43(12):1565-1577.
35. Committee on Infectious Diseases Policy statement-recommended childhood and adolescent immunization schedules-United States, 2011. Pediatrics 2011, 127(2):387-388.
36. Fireman B., Lee J., Lewis N., Bembom O., van der Laan M., Baxter R. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol 2009, 170(5):650-656.
37. Baxter R., Lee J., Fireman B. Evidence of bias in studies of influenza vaccine effectiveness in elderly patients. J Infect Dis 2010, 201(2):186-189.
38. Klein N.P., Fireman B., Yih W.K., et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 2010, 126(1):e1-e8.
39. Koskiniemi M., Korppi M., Mustonen K., et al. Epidemiology of encephalitis in children. A prospective multicentre study. Eur J Pediatr 1997, 156(7):541-545.
40. Plotkin S.A., Orenstein W.A., Offit P.A. Vaccines 2008, Saunders/Elsevier, Philadelphia. 5th ed.
41. Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996, 45(RR-12):1-35.
42. Mailles A., Stahl J.P. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 2009, 49(12):1838-1847.
43. Berkovic S.F., Harkin L., McMahon J.M., et al. De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study. Lancet Neurol 2006, 5(6):488-492.
44. Reyes I.S., Hsieh D.T., Laux L.C., Wilfong A.A. Alleged cases of vaccine encephalopathy rediagnosed years later as Dravet syndrome. Pediatrics 2011, 128:e699-e702.
45. Granerod J., Crowcroft N.S. The epidemiology of acute encephalitis. Neuropsychol Rehabil 2007, 17(4/5):406-428.
46. Glanz J.M., McClure D.L., Xu S., et al. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol 2006, 59(8):808-818.
47. Whitaker H.J., Hocine M.N., Farrington C.P. The methodology of self-controlled case series studies. Stat Methods Med Res 2008.